Vaxcyte reported for 2021 Vaxcyte from 3/1/22

User image

Sergey Novikov

News editor
press@blackterminal.com

Vaxcyte's GAAP loss for 2021 was $100.077 million, up 12.2% from $89.217 million the previous year.

Vaxcyte

PCVX

$89.64

+1.41%

Review

Source:

{source} pictogram

investors.vaxcyte.com

Sergey Novikov

News editor

Write your comment first

News feed

Element and Aquarius agreed on the supply of server power supplies

6/4/25 ELMT

NCSP to redeem treasury shares

6/4/25 VMTP

Moscow Exchange launched trading of Russia's first crypto futures

6/4/25 MOEX

Gazprom postpones plans to create a gas hub in Turkey

6/4/25 GAZP

Ingrad will change its stock ticker

6/4/25 INGR

Board of Directors of Rosseti Moscow Region recommended that dividends be paid for 2024

6/3/25 MSRS

MTS intends to occupy 25% of the Belarusian corporate communications market

6/3/25 MTSS

Board of Directors of Pharmsintez proposed an additional share issue

6/3/25 LIFE

Magnit will launch a new format of stores Charge from Magnit

6/3/25 MGNT

Fesco bought the operator of the Kaliningrad Sea Fishing Port

6/3/25 FESH